ArticleNeurology and therapy2024

Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study.

Taoufik Alsaadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.